Your browser doesn't support javascript.
loading
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study.
Bartelt, Luther A; Markmann, Alena J; Nelson, Bridget; Keys, Jessica; Root, Heather; Henderson, Heather I; Kuruc, JoAnn; Baker, Caroline; Bhowmik, D Ryan; Hou, Yixuan J; Premkumar, Lakshmanane; Cornaby, Caleb; Schmitz, John L; Weiss, Susan; Park, Yara; Baric, Ralph; de Silva, Aravinda M; Lachiewicz, Anne; Napravnik, Sonia; van Duin, David; Margolis, David M.
  • Bartelt LA; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Markmann AJ; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Nelson B; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Keys J; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Root H; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Henderson HI; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Kuruc J; The AIDS Center at Montefiore, Division of Infectious Diseases, Montefiore Medical Center, Bronx, New York, USA.
  • Baker C; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Bhowmik DR; Department of Medicine, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Hou YJ; UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Premkumar L; UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Cornaby C; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Schmitz JL; Department of Epidemiology, University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA.
  • Weiss S; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Park Y; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Baric R; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • de Silva AM; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Lachiewicz A; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Napravnik S; Department of Pathology, Carolinas Pathology Group, Atrium Health Carolinas Medical Center, Charlotte, North Carolina, USA.
  • van Duin D; Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Margolis DM; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
mBio ; 13(5): e0175122, 2022 10 26.
Article en En | MEDLINE | ID: mdl-36135380
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Humans Idioma: En Año: 2022 Tipo del documento: Article